Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$185.52 - $231.25 $729,835 - $909,737
-3,934 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$143.0 - $274.03 $562,562 - $1.08 Million
3,934 New
3,934 $771,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Ativo Capital Management LLC Portfolio

Follow Ativo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ativo Capital Management LLC with notifications on news.